SHIFT Newsroom · GLOBAL
Oral semaglutide delivery system studied in laboratory and mouse experiments
Researchers in the Journal of Controlled Release investigated an experimental nanomicelle delivery system using laboratory models and mice with diet-induced obesity.
Researchers in the Journal of Controlled Release investigated an experimental nanomicelle delivery system using laboratory models and mice with diet-induced obesity. They reported improved absorption and metabolic outcomes under those experimental conditions. These are preclinical findings, not patient-trial results, and cannot establish an effective human dose, human safety or equivalence to an authorised semaglutide product.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.